• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19.

作者信息

Xie Yun, Cao Song, Dong Hui, Li Qingyun, Chen Erzhen, Zhang Wenkai, Yang Luyu, Fu Shouzhi, Wang Ruilan

机构信息

Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, 650 New Songjiang Road, Songjiang, 201600, Shanghai, China.

Department of Critical Care Medicine, Wuhan Third Hospital,Wuhan University, 216 Guanshan avenue, Hongshan district, Wuhan, 430070, Hubei, China.

出版信息

J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.03.044. Epub 2020 Apr 10.

DOI:10.1016/j.jinf.2020.03.044
PMID:32283154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7151471/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/7151471/cc136502f1af/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/7151471/c2e1b53a7e9d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/7151471/cc136502f1af/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/7151471/c2e1b53a7e9d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b7b/7151471/cc136502f1af/gr2_lrg.jpg

相似文献

1
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19.常规静脉注射免疫球蛋白治疗对新型冠状病毒肺炎（COVID-19）重症肺炎患者预后的影响。
J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.03.044. Epub 2020 Apr 10.
2
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?新型冠状病毒2型感染并发炎症综合征。静脉注射用大剂量人免疫球蛋白（IVIG）是否有益？
Autoimmun Rev. 2020 Jul;19(7):102559. doi: 10.1016/j.autrev.2020.102559. Epub 2020 May 1.
3
Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend?皮质类固醇在SARS-CoV-2感染中的应用：是敌，还是能成为友？
Pol Arch Intern Med. 2020 Oct 29;130(10):922. doi: 10.20452/pamw.15661.
4
Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin.一名2019冠状病毒病患者在接受静脉注射免疫球蛋白治疗后出现阳性结果，该患者同时患有常见变异型免疫缺陷。
Ann Allergy Asthma Immunol. 2020 Sep;125(3):349-350. doi: 10.1016/j.anai.2020.06.006. Epub 2020 Jun 4.
5
Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend? Authors' reply.SARS-CoV-2感染中皮质类固醇的使用：是敌，还是能成为友？作者回复
Pol Arch Intern Med. 2020 Oct 29;130(10):922-923. doi: 10.20452/pamw.15662.
6
Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?新型冠状病毒肺炎重症肺炎中的出血：异常凝血模式的另一面？
Eur J Intern Med. 2020 Jul;77:147-149. doi: 10.1016/j.ejim.2020.05.002. Epub 2020 May 7.
7
Coagulation profile in severe COVID-19 patients: what do we know so far?重症 COVID-19 患者的凝血情况：我们目前了解多少？
Rev Bras Ter Intensiva. 2020 Jun;32(2):197-199. doi: 10.5935/0103-507x.20200031. Epub 2020 Jun 24.
8
Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.新型冠状病毒肺炎住院患者中严重急性呼吸综合征冠状病毒2诱导的凝血病与预后：来自意大利的一则简讯
Thromb Haemost. 2020 Aug;120(8):1233-1236. doi: 10.1055/s-0040-1712918. Epub 2020 May 26.
9
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vertical Transmission in Neonates Born to Mothers With Coronavirus Disease 2019 (COVID-19) Pneumonia.2019冠状病毒病（COVID-19）肺炎母亲所生新生儿中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的垂直传播
Obstet Gynecol. 2020 Sep;136(3):632-633. doi: 10.1097/AOG.0000000000004073.
10
COVID-19 Coagulopathy: Considerations for Urologists.新型冠状病毒肺炎凝血功能障碍：泌尿外科医生的考量
J Urol. 2020 Oct;204(4):640-641. doi: 10.1097/JU.0000000000001144. Epub 2020 May 18.

引用本文的文献

1
Treatment with intravenous immunoglobulin modulates coagulation- and complement-related pathways in COVID-19 patients.静脉注射免疫球蛋白治疗可调节新冠肺炎患者的凝血和补体相关途径。
Front Immunol. 2025 Jul 31;16:1623309. doi: 10.3389/fimmu.2025.1623309. eCollection 2025.
2
Effects of colchicine, interferon β, IVIG, tocilizumab and corticosteroids on COVID-19 patient survival from all presently available published clinical trials: A narrative review.秋水仙碱、干扰素β、静脉注射免疫球蛋白、托珠单抗和皮质类固醇对COVID-19患者生存的影响：基于所有现有已发表临床试验的叙述性综述。
Caspian J Intern Med. 2025 Mar 11;16(2):198-214. doi: 10.22088/cjim.16.2.198. eCollection 2025.
3

本文引用的文献

1
Coronavirus 2019-nCoV: A brief perspective from the front line.新型冠状病毒 2019-nCoV：来自前线的简要观察。
J Infect. 2020 Apr;80(4):373-377. doi: 10.1016/j.jinf.2020.02.010. Epub 2020 Feb 25.
2
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
3
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies.
急性呼吸窘迫综合征的进展：聚焦于异质性、病理生理学和治疗策略。
Signal Transduct Target Ther. 2025 Mar 7;10(1):75. doi: 10.1038/s41392-025-02127-9.
4
Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease.抗体聚集：生物制药行业中的一个问题及其在AL淀粉样变性疾病中的作用。
Protein J. 2025 Feb;44(1):1-20. doi: 10.1007/s10930-024-10237-6. Epub 2024 Nov 11.
5
Evaluation of the Efficacy and Safety of Intravenous Immunoglobulin (IVIG) in Moderate-to-Severe Hospitalized COVID-19 Patients: A Randomized, Open-Label Parallel-Group Study.静脉注射免疫球蛋白（IVIG）治疗中重度住院COVID-19患者的疗效和安全性评估：一项随机、开放标签平行组研究。
Can J Infect Dis Med Microbiol. 2024 May 21;2024:7209380. doi: 10.1155/2024/7209380. eCollection 2024.
6
Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report.静脉注射免疫球蛋白治疗免疫功能低下患者的持续性 COVID-19：简要报告。
Front Immunol. 2024 Apr 19;15:1399180. doi: 10.3389/fimmu.2024.1399180. eCollection 2024.
7
Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer.抗血管生成药物对非小细胞肺癌患者新冠病毒病严重程度的影响
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241248573. doi: 10.1177/15330338241248573.
8
A study of factors affecting the length of hospital stay (LOS) of COVID-19 patients: A qualitative evidence in Iranian hospital.一项关于影响新冠病毒疾病患者住院时长因素的研究：来自伊朗医院的定性证据
J Educ Health Promot. 2023 Nov 27;12:403. doi: 10.4103/jehp.jehp_1576_22. eCollection 2023.
9
Passive antibody therapy in emerging infectious diseases.新发传染病中的被动抗体疗法。
Front Med. 2023 Dec;17(6):1117-1134. doi: 10.1007/s11684-023-1021-y. Epub 2023 Dec 2.
10
Blood-derived product therapies for SARS-CoV-2 infection and long COVID.用于治疗SARS-CoV-2感染和长期新冠的血液衍生产品疗法。
MedComm (2020). 2023 Nov 15;4(6):e426. doi: 10.1002/mco2.426. eCollection 2023 Dec.
《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
4
Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review.目前的治疗选择和肽作为中东呼吸综合征（MERS）潜在治疗成分的作用：综述。
J Infect Public Health. 2018 Jan-Feb;11(1):9-17. doi: 10.1016/j.jiph.2017.08.009. Epub 2017 Aug 31.
5
Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection.静脉注射免疫球蛋白可预防严重大流行性流感感染。
EBioMedicine. 2017 May;19:119-127. doi: 10.1016/j.ebiom.2017.04.010. Epub 2017 Apr 6.
6
Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study.静脉注射免疫球蛋白与脓毒性休克肺炎患者的死亡率：一项全国性观察研究。
Clin Infect Dis. 2015 Aug 1;61(3):385-92. doi: 10.1093/cid/civ307. Epub 2015 Apr 16.
7
Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.静注人免疫球蛋白（pH4）治疗严重 2009 年甲型 H1N1 流感的多中心、双盲、随机对照临床研究
Chest. 2013 Aug;144(2):464-473. doi: 10.1378/chest.12-2907.
8
SARS: systematic review of treatment effects.严重急性呼吸综合征：治疗效果的系统评价
PLoS Med. 2006 Sep;3(9):e343. doi: 10.1371/journal.pmed.0030343.
9
Immunoglobulin a modulates inflammatory responses in an in vitro model of pneumonia.免疫球蛋白A在肺炎体外模型中调节炎症反应。
J Trauma. 2005 Nov;59(5):1099-106. doi: 10.1097/01.ta.0000187797.38327.78.
10
Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency.静脉注射免疫球蛋白预防普通可变免疫缺陷患者肺炎的疗效
J Allergy Clin Immunol. 2002 Jun;109(6):1001-4. doi: 10.1067/mai.2002.124999.